Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP2793776B2 - Enema - Google Patents
[go: Go Back, main page]

JP2793776B2 - Enema - Google Patents

Enema

Info

Publication number
JP2793776B2
JP2793776B2 JP6207282A JP20728294A JP2793776B2 JP 2793776 B2 JP2793776 B2 JP 2793776B2 JP 6207282 A JP6207282 A JP 6207282A JP 20728294 A JP20728294 A JP 20728294A JP 2793776 B2 JP2793776 B2 JP 2793776B2
Authority
JP
Japan
Prior art keywords
preservative
enema
solution
concentration
plasticizer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP6207282A
Other languages
Japanese (ja)
Other versions
JPH0867791A (en
Inventor
雅之 本田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shin Etsu Polymer Co Ltd
Original Assignee
Shin Etsu Polymer Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Etsu Polymer Co Ltd filed Critical Shin Etsu Polymer Co Ltd
Priority to JP6207282A priority Critical patent/JP2793776B2/en
Publication of JPH0867791A publication Critical patent/JPH0867791A/en
Application granted granted Critical
Publication of JP2793776B2 publication Critical patent/JP2793776B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、浣腸器内における浣腸
液中の防腐剤濃度の減少を防止した、衛生面に優れた新
規な浣腸器に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel hygiene enema which prevents a decrease in the concentration of a preservative in an enema fluid in the enema.

【0002】[0002]

【従来の技術】浣腸器用の容器は、衛生面の向上や看護
者の洗浄負担を軽減するために、ガラス製シリンジ型か
らディスポーザブルタイプの汎用樹脂製無花果型へと
遷し、この汎用樹脂製容器に浣腸液を封入した浣腸器
広く流通している。これに使用される汎用樹脂として
は、ポリエチレン系、ポリプロピレン系、ポリ塩化ビニ
ル系などがある。この中でも塩化ビニル系樹脂製容器
は、浣腸液を吐出させるときの変形押圧力が低く、復元
応答性がよいため、操作性や手触感に優れている。また
塩化ビニル系樹脂は、ブロー成形性が良い点や低価格の
点においても、汎用樹脂の中で群を抜いている。しか
し、従来の塩化ビニル系樹脂製容器を用いた浣腸器で
は、浣腸液中の防腐剤濃度が保存中に減衰し、早いもの
で封入後 1.5カ月程度経過すると浣腸器内に細菌やカビ
が発生し、これを誤って使用すると肛門から直腸にかけ
て炎症を起こすという問題があり、普及に至っていな
い。また、この防腐剤濃度減少の原因も不明であった。
[Prior Art] EnemaDexterousContainers should be used to improve hygiene and nursing
Glass syringe type to reduce
Disposable general-purpose resin figsToStrange
The enema was sealed in this general-purpose resin containerEnemaBut
WideIt is in circulation. As a general-purpose resin used for this
Means polyethylene, polypropylene, polyvinyl chloride
And others. Among them, containers made of vinyl chloride resin
Discharges the enemaWhenThe deformation pressing force is low and it is restored
Due to its good responsiveness, it is excellent in operability and feel. Also
Vinyl chloride resin has good blow moldability and low cost.
In terms of points, it is also a leader among general-purpose resins. Only
And an enema using a conventional vinyl chloride resin containerIn a bowl
Indicates that the preservative concentration in the enema drops off during storage,
About 1.5 months after encapsulation, bacteria and mold will remain in the enema.
If you use it incorrectly, it will go from the anus to the rectum.
Problem of causing inflammation due to
No. Also, the cause of the decrease in the preservative concentration was unknown.

【0003】[0003]

【発明が解決しようとする課題】本発明は、従来塩化
ビニル系樹脂製容器の持つ操作性や優れた手触感、成形
性を保持しながら、その浣腸液中の防腐剤濃度が減少し
使用に耐えなくなるという欠点を克服した、浣腸器
供を目的とする。
[SUMMARY OF THE INVENTION The present invention, operability and excellent hand touch with a conventional vinyl resin vessel chloride, molding
While retaining the sex, preservative concentration in the enema liquid is reduced
Overcame the disadvantage of a withstand use Kunar, an object of Hisage <br/> supply of enema.

【0004】[0004]

【課題を解決するための手段】本発明は塩化ビニル系
樹脂製容器を用いた浣腸の防腐剤濃度減少を一定範
囲に保つことを目的に鋭意研究を重ねた結果、塩化ビニ
ル系樹脂に所定量の防腐剤を練りこむことによって
の目的達成されることを見出し完成したもので、塩
化ビニル系樹脂 100重量部可塑剤10〜 150重量部及び
から求めた防腐剤F重量部からなる塩化ビニル
系樹脂製容器内に、防腐剤濃度0.015 〜0.06w/v%の浣腸
液が封入されてなることを特徴とする浣腸器に係る。 F=CbE/(100Cb) …………式1 [ここで、bは浣腸液と可塑剤及び防腐剤の共存時にお
ける防腐剤の浣腸液への分配比を1としたときの、防腐
剤の可塑剤への分配比、Cは浣腸液中で維持すること
必要な防腐剤濃度(w/v%)で、浣腸液 100ml中の防腐剤
重量gで表わす、Eは可塑剤添加重量部、dはCb/
100(mol/ml) で表わされる防腐剤入りの可塑剤溶液
の密度(g/ml)Mは防腐剤の分子量をそれぞれ表わ
す。
SUMMARY OF THE INVENTION The present invention relates to a vinyl chloride system.
Results in a decrease of the preservative concentration enema using resin container stacked intensive studies with the aim of maintaining a constant range by kneading a predetermined amount of preservative in the vinyl chloride resin, the purpose is achieved is been completed by finding Rukoto, 100 parts by weight of vinyl chloride resin, a plasticizer 10 to 150 parts by weight and <br/> consisting preservative F parts by weight calculated from the bottom following formula 1 made of vinyl chloride resin In the container, enema with preservative concentration 0.015 ~ 0.06w / v%
The present invention relates to an enema, wherein a liquid is sealed. F = CbE / (100 d - Cb) ............ formula 1 [where, b is the time of the 1 the distribution ratio of the enema liquid preservative at coexistence of enemas and plasticizers and preservatives, distribution ratio to plasticizers preservatives, C is at <br/> necessary preservative concentration be maintained at enema solution (w / v%), a preservative in an enema solution 100ml
Expressed in weight g, E is added parts by weight of a plasticizer, d is Cb /
100 M (mol / ml) density of the plasticizer solution preservatives containing represented by (g / ml), M each table a molecular weight of preservative
You. ]

【0005】以下に本発明を詳細に説明する。本発明に
使用する防腐剤は、浣腸液に用いられているものと同じ
ものを、塩化ビニル系樹脂に添加する。これら防腐剤は
人体への安全性が高いものを極力使用することが重要で
ある。すなわち、安息香酸、ソルビン酸及びその塩類、
p−ヒドロキシ安息香酸エステル、デヒドロ酢酸、プロ
ピオン酸及びその塩類、ジフェニル、o−フェニルフェ
ノール、チアベンダゾールなど食品添加物公定書に許可
されたものを用いるのがい。これらの塩類、エステル
類には安息香酸ナトリウム、ソルビン酸カリウム、p−
ヒドロキシ安息香酸イソブチル、p−ヒドロキシ安息香
酸イソプロピル、−ヒドロキシ安息香酸、p−ヒドロ
キシ安息香酸エチル、p−ヒドロキシ安息香酸ブチル、
p−ヒドロキシ安息香酸プロピル、デヒドロ酢酸ソー
ダ、プロピオン酸カルシウム、プロピオン酸ナトリウ
ム、ナトリウムオルソフェニルフェノラートが例示され
る。その他に化粧品原料基準、日本薬局法などに規定の
ナフテン酸、β−ナフトール、p−ニトロフェノールが
挙げられる。
Hereinafter, the present invention will be described in detail. As the preservative used in the present invention, the same preservative used in the enema solution is added to the vinyl chloride resin. It is important to use those preservatives that are highly safe for the human body as much as possible. That is, benzoic acid, sorbic acid and its salts,
p- hydroxybenzoic acid esters, dehydroacetic acid, propionic acid and its salts, diphenyl, o- phenylphenol, have good to use those authorized as a food additive compendia such as thiabendazole. These salts and esters include sodium benzoate, potassium sorbate, p-
Isobutyl hydroxybenzoate, isopropyl p -hydroxybenzoate, p-hydroxybenzoic acid, ethyl p-hydroxybenzoate, butyl p-hydroxybenzoate,
Examples are propyl p-hydroxybenzoate, sodium dehydroacetate, calcium propionate, sodium propionate, sodium orthophenylphenolate . Other examples include naphthenic acid, β-naphthol, and p-nitrophenol, which are defined by the standard for cosmetic raw materials and the Japanese Pharmacopoeia Law.

【0006】 ここで本発明で用いる濃度単位を説明する
と、浣腸液中の防腐剤濃度C(w/v%は(防腐剤重量
/浣腸液の容積 100ml)、モル濃度mol/mlは(溶質モル
数/溶液の容積1ml)、後記実施例に用いた重量濃度w/
w%は(溶質重量g/溶液重量100)のように各々括弧
内の数値を示す。
The concentration unit used in the present invention will now be described. The preservative concentration C ( w / v% ) in the enema solution is (weight of preservative g
/ Enema liquid volume 100 ml), molar concentration mol / ml (mol number of solute / solution volume 1 ml), weight concentration w /
w% indicates the value of each in brackets as (solute weight g / solution weight 100 g).

【0007】浣腸液は、一般にグリセリンと水の混合液
に防腐剤を溶解したものが用いられており、また栄養補
給用に目的に応じた薬剤や滋養分が添加されている。こ
れら浣腸液に用いる防腐剤は、1種あるいは2種以上を
組み合せて、その合計濃度0.015 〜0.06w/v%に調整す
るのが好ましい。0.015w/v% 未満では防腐効果がなく、
0.06w/v%をえると個人差はあるものの粘膜や皮膚に刺
激を与え易くなる。特には0.02w/v%から0.04w/v%とする
のが好ましい。流通在庫を持って、ユーザーでも半年以
上の使用保証期間をとるには、この範囲の濃度を1年以
上維持させる必要がある。
As the enema, a solution obtained by dissolving a preservative in a mixture of glycerin and water is generally used, and an appropriate drug or nutrient is added for nutritional supplementation. The preservatives used in these enema solutions are preferably used alone or in combination of two or more, and the total concentration is preferably adjusted to 0.015 to 0.06 w / v%. 0.015w / v there is no preservative effect in less than%,
0.06 w / v% ultra Ell and individual differences easily irritate the mucous membranes and skin of some. In particular, have preferred that to 0.04w / v% from 0.02w / v%. In order for a user to have a distribution inventory and a use guarantee period of more than six months, it is necessary to maintain the concentration in this range for one year or more.

【0008】発明者は浣腸液中の防腐剤塩化ビニル
系樹脂製容器に含まれている可塑剤に浸透することによ
って減少することを発見した。発明者はまた浣腸液中
の必須防腐剤濃度を維持するには、グリセリン水溶液と
可塑剤を共存させたときに、グリセリン水溶液中の防腐
剤がいかに可塑剤とグリセリン水溶液に分配されて溶解
するか分配比を測定し、浣腸液中に維持安定させたい防
腐剤濃度に分配比bを乗じて塩化ビニル系樹脂に練り込
む防腐剤量を定め、塩化ビニル系樹脂製容器にすればよ
いことを見した。
[0008] The present inventors have found that reduced by penetrating the plasticizer preservative in enemas is included in the vinyl resin container chloride. To maintain the required preservative concentration inventors also enema solution, when allowed to coexist aqueous glycerol solution and a plasticizer, a preservative in an aqueous glycerol solution is how dissolved is distributed plasticizer glycerin aqueous solution The distribution ratio is measured, and the preservative concentration to be maintained and stabilized in the enema solution is multiplied by the distribution ratio b to determine the amount of the preservative to be kneaded into the vinyl chloride resin . It was heading.

【0009】分配比を求める方法について二つの例を挙
げて説明する。まず第1例を説明する。任意量の防腐剤
をグリセリン水溶液及び/または可塑剤に溶解させ、こ
の2つの溶液を分液ロートに入れ60分以上激しく振とう
させてから、これが2層に分離するまで静置する。これ
は3日以上静置することが望ましい。分離したそれぞれ
の層に溶解している防腐剤濃度を定量し、モル濃度(mo
l/ml)比または重量/容積濃度(w/v%)比を分配比とす
る。防腐剤の定量は公知のGCP分析によって行われ
る。予め、使用される防腐剤の液体クロマトグラフ通過
時間(保持時間)と防腐剤の極大吸収波長で吸光度−濃
度の検量線を作製しておき、続いて各層の溶液を液体ク
ロマトグラフにかけ、これに検量線作製に用いた波長光
を当て、保持時間から防腐剤を同定、分離して、吸光度
から濃度を求める。これの操作は浣腸が保持及び使用
される代表的な温度23℃で行えばよく、特には−10℃か
ら50℃について10℃刻みで測定し、7点の平均とするの
がよい。
The method for obtaining the distribution ratio will be described with reference to two examples. First, a first example will be described. An arbitrary amount of a preservative is dissolved in an aqueous glycerin solution and / or a plasticizer, and the two solutions are placed in a separatory funnel and shaken vigorously for 60 minutes or more, and then allowed to stand until they separate into two layers. This is desirably left for at least three days. The concentration of the preservative dissolved in each separated layer was quantified, and the molar concentration (mo
l / ml) ratio or weight / volume concentration (w / v%) ratio is defined as the distribution ratio. The quantification of the preservative is performed by a known GCP analysis. Beforehand, a calibration curve of absorbance-concentration is prepared based on the preservative passage time (retention time) of the preservative used and the maximum absorption wavelength of the preservative, and then the solution of each layer is subjected to liquid chromatography, and The preservative is identified and separated from the retention time by applying the wavelength light used for preparing the calibration curve, and the concentration is determined from the absorbance. This operation may be performed in a representative temperature 23 ° C. the enema is retained and used, in particular, measured at 10 ° C. increments for 50 ° C. from -10 ° C., preferably set to an average of 7 points.

【0010】第1の例ではグリセリン水溶液と可塑剤と
の間で防腐剤分配比を定量したが、グリセリン水溶液と
塩化ビニル系樹脂組成物間でも分配比を定量すること
ができる。これを第2例として説明する。任意量の防腐
剤をグリセリン水溶液及び/または塩化ビニル系樹脂組
成物に溶解または混合させ、この塩化ビニル系樹脂組成
物をシートに成形し、シートを前記グリセリン水溶液に
40日以上浸すか、あるいはこの塩化ビニル系樹脂組成物
で浣腸器用の容器を成形し、これに前記グリセリン水溶
液を注入し40日以上放置して平衡に到達させる以外は、
第1例と同じ方法を取る。ただし、塩化ビニル系樹脂組
成物中の可塑剤と防腐剤はエーテルで抽出し定量す
る。
[0010] In the first example was quantified preservative distribution ratio between aqueous glycerol solution and a plasticizer, it can also be quantified distribution ratio between the aqueous glycerol solution and vinyl chloride resin composition. This will be described as a second example. An arbitrary amount of preservative is dissolved or mixed in the glycerin aqueous solution and / or the vinyl chloride resin composition, and the vinyl chloride resin composition is formed into a sheet, and the sheet is added to the glycerin aqueous solution.
Except for soaking for 40 days or more, or forming a container for an enema with this vinyl chloride resin composition, injecting the glycerin aqueous solution into this and leaving it for 40 days or more to reach equilibrium,
Take the same method as in the first example. However, plasticizers and preservatives in the vinyl chloride-based resin composition is quantified by extraction with ether.

【0011】 これら2例とも、分配後の2層の防腐剤濃
度が解ればく、設置する前の各層について防腐剤濃度
は不明でもかまわない。また逆に2層を設置する前の各
層について、防腐剤濃度と、層重量または/層体積と密
度を知り、密閉系で防腐剤を分配させれば、質量保存の
法則を使って、分配後の防腐剤濃度測定はどちらか1層
行えばい。これら2例の内では短期間で測定でき簡便
であることから第1例が推奨されるが、分配比測定法
は、互いに混じり合わないグリセリン水溶液層と可塑剤
層が共存している状態で、これら両層いずれにも溶解し
うる防腐剤が、どんな濃度で両層に分配され平衡に達す
るかを測定すればよく、その操作方法はこれら2例に限
定されるものではない。
[0011] These both cases, rather than by if antiseptic concentration of the two-layer after the distribution is known, preservatives concentration for each layer prior to installation may even unknown. Conversely, for each layer before installing the two layers, know the preservative concentration, layer weight or / layer volume and density, and if the preservative is distributed in a closed system, using the law of conservation of mass, the preservative concentration measurement has good be carried out either one layer. Of these two examples , the first example is recommended because it can be measured in a short period of time and is simple, but the distribution ratio measurement method is based on the condition that a glycerin aqueous solution layer and a plasticizer layer that do not mix with each other coexist. What is necessary is just to measure the concentration of the preservative that can be dissolved in both of these layers and reach equilibrium in both layers, and the operation method is not limited to these two examples.

【0012】このようにして求められた防腐剤の分配
即ちグリセリン水溶液の防腐剤濃度(mol/ml)と可
塑剤の防腐剤濃度(mol/ml)の比A/Bを使って、浣腸
液中の防腐剤濃度を(w/v%)に維持させるために塩化
ビニル系樹脂に練りこむ防腐剤量F(重量部)は、前記
式1で求められる。その際この濃度の防腐剤入りの可
塑剤溶液の密度d(g/ml)を測定し、式1に代入する必
要がある。
Using the thus obtained partition ratio of the preservative , that is, the ratio A / B of the preservative concentration (mol / ml) of the aqueous glycerin solution to the preservative concentration (mol / ml) of the plasticizer, the enema is obtained. The amount F (parts by weight) of the preservative kneaded into the vinyl chloride resin to maintain the preservative concentration in the liquid at C (w / v%) is determined by the above formula 1. At that time , it is necessary to measure the density d (g / ml) of the plasticizer solution containing the preservative of this concentration and substitute it into the equation (1).

【0013】式1を説明する。A…浣腸液と可塑剤の共
存時における防腐剤の浣腸液への分配比、B…浣腸液と
可塑剤の共存時における防腐剤の可塑剤への分配比と
し、特にA=1のときのBをbで表す。浣腸液中に維持
させたい防腐剤濃度を(w/v%)とし、これをモル濃度
換算すると/100(mol/ml)となる(M…防腐剤の分
子量)したがって浣腸液中に/100(mol/ml)の濃
度の防腐剤を維持させるために必要な可塑剤中の防腐剤
濃度(mol/ml)はCb/100となる。濃度(mol/m
l)の防腐剤入りの可塑剤溶液の密度(g/ml) を測定
し、(mol/ml)の防腐剤入りの可塑剤溶液1中の可
塑剤重量を求めると、(1−XM/d) となる。XM/
防腐剤入りの可塑剤溶液1中の防腐剤量で残り
は可塑剤(1−XM/d) となる。これにX=Cb/100
を代入すると、1−XM/dは1−Cb/(100)に
なる。これは濃度(mol/ml)の防腐剤入りの可塑剤溶
液1中の可塑剤重量になる。
Equation 1 will be described. A: distribution ratio of preservative to enema when coexisting with enema and plasticizer; B: distribution ratio of preservative to plasticizer when coexisting of enema and plasticizer, especially when A = 1 B is represented by b. The concentration of the preservative to be maintained in the enema is defined as C (w / v%), which is converted into a molar concentration to be C / 100 M (mol / ml) (M: molecular weight of the preservative) . Therefore, the preservative concentration X (mol / ml) in the plasticizer required to maintain the preservative at a concentration of C / 100 M (mol / ml) in the enema is Cb / 100 M. Concentration X (mol / m
measuring the preservative containing plasticizers density of the solution d of l) (g / ml), when obtaining the plasticizer weight of a preservative-containing plasticizer solution 1 in g of X (mol / ml), ( 1- XM / d) . XM /
d is a preservative amount of a plasticizer solution 1 in g preservative containing the remainder becomes a plasticizer (1-XM / d). X = Cb / 100
When M is substituted , 1-XM / d becomes 1-Cb / ( 100d ). This becomes a plasticizer weight g in plasticizer solution 1 g of a preservative containing a concentration X (mol / ml).

【0014】 塩化ビニル系樹脂製容器の作製のために、
塩化ビニル系樹脂 100重量部に対して可塑剤をE重量部
添加したいとき、浣腸液中の必須防腐剤濃度を維持させ
のに必要な防腐剤添加量F(重量部)は、MCb
(100Md)]×[/(1−Cb/100)]=CbE/(100d
Cb) (式1)で表される。この式1を説明する
と、XM/d=(Cb/100M)M/d=MCb/100Md
となり、MCb/(100Md)]は(mol/ml)を防腐剤
入りの可塑剤溶液1当たりの防腐剤重量に換算した
もので単位は g/gになる。[/(1−Cb/100)]は可
塑剤Eを含む(mol/ml)の防腐剤入りの可塑剤溶液
かを計算したもので単位はになる。したがっ
て可塑剤Egに防腐剤を添加して(mol/ml)の防腐剤
入りの可塑剤溶液とするには、MCb/(100Md)×
/(1−Cb/100)]の防腐剤が必要で、まとめる
CbE/(100Cb) gになる。可塑剤Egを塩化
ビニル系樹脂 100に対する添加量とすれば、可塑剤E
重量部、防腐剤F重量部に変換できる。
In order to produce a vinyl chloride resin container,
When it is desired to add E parts by weight of the plasticizer to 100 parts by weight of the vinyl chloride resin, the preservative addition amount F (parts by weight) required to maintain the essential preservative concentration in the enema is [ MCb /
(100 Md)] × [E / (1- Cb / 100 d)] = CbE / (100d
- represented by Cb) ... (Equation 1). Explaining this equation 1, XM / d = (Cb / 100M) M / d = MCb / 100Md
Next, [MCb / (100 Md) ] is X (mol / ml) of preservative
The unit is g / g in terms of the weight of preservative per g of the plasticizer solution containing g . [E / (1- Cb / 100 d)] a solution plasticizers preservatives containing the X (mol / ml) containing a plasticizer E g
Is what g is calculated, and the unit is g . Therefore, the preservative of X (mol / ml) is added by adding a preservative to the plasticizer Eg.
To the congestion of plasticizer solution, MCb / (100 Md) ×
It becomes - (Cb 100 d) g [ E / (1- Cb / 100 d)] requires preservative g, summary CbE /. If the plasticizer Eg is added to 100 g of the vinyl chloride resin, the plasticizer E
Parts by weight, can be converted to F parts by weight of preservative.

【0015】これまでの検討から、式1で求められた防
腐剤F重量部添加した塩化ビニル系樹脂製容器の浣腸
液中の防腐剤の維持率は、実施例記載の検体10個で、母
平均μ、母分散σ2としたときのμ±3σが(95.3±2.
40)%であった。防腐剤が僅かに減少する原因は分配比
測定が促進試験で完全平衡前に測定されていることや、
成形中の熱によって選択的に防腐剤が蒸発損失している
こと、可塑剤以外の組成物に防腐剤が若干吸収されてい
ること、第2例では容器からの抽出率の問題などが考え
られるが、原因を特定するには至っていない。しかしな
がら防腐剤初期濃度(維持させたい防腐剤濃度)Cを、
(95.3±2.40)%の維持率を考慮して安全を見て0.015w
/v% から0.06w/v%の間に設定すれば、式1で求めたF
(重量部)の防腐剤を練りこんだ塩化ビニル系樹脂製容
器の浣腸液中の防腐剤濃度は、最も好ましい0.02w/v%か
ら0.04w/v%の範囲で安定させること容易である。
From the previous studies, the retention rate of the preservative in the enema solution of the vinyl chloride resin container to which the preservative F (parts by weight) determined by Formula 1 was added was 10 specimens described in the Examples. Μ ± 3σ when population average μ and population variance σ2 are (95.3 ± 2.
40)%. Preservatives are slightly reduced because the partition ratio measurement is measured before full equilibrium in accelerated tests,
It can be considered that the preservative is selectively evaporated and lost by heat during molding, that the preservative is slightly absorbed by the composition other than the plasticizer, and that the second example is problematic in terms of the extraction rate from the container. However, the cause has not been identified. However, the preservative initial concentration (preservative concentration to be maintained) C is
Considering the maintenance rate of (95.3 ± 2.40)%, seeing safety 0.015w
/ v% to 0.06w / v%, F
It is easy to stabilize the preservative concentration in the enema of the vinyl chloride resin container into which (parts by weight) preservative is kneaded, in the most preferable range of 0.02 w / v% to 0.04 w / v%. .

【0016】この防腐剤塩化ビニル系樹脂へ練りこむ
方法は特に制限は無く、式1で求めた防腐剤F重量
部、可塑剤E重量部と後述する塩化ビニル系樹脂 100重
量部や各種添加成分を所定部数、リボンブレンダー、ヘ
ンシェルミキサー、高速ミキサーなどの配合機で分散溶
解する方法や更にこの塩化ビニル系樹脂組成物を単軸ま
たは2軸押出機、バンバリーミキサー、加圧ニーダー、
コニーダー、ロールなどの混練機を用いて均質に混練分
散溶解する方法を取ればよい。また配合機で分散溶解す
る前に、予め可塑剤に防腐剤を溶解させる工程を取って
も取らなくても、防腐剤減少防止効果に差は認められな
かった。このようにして分散溶解された防腐剤入り塩化
ビニル系樹脂組成物は、粉体、ブロック体、シートある
いはペレットとして、次の浣腸器用容器成形工程に送
られる。
[0016] The preservative particular limitations on the method of kneading the vinyl chloride resin without preservatives F parts by weight as determined by the formula 1, plasticizer E parts by weight vinyl chloride resin 100 parts by weight of various described later A method of dispersing and dissolving a predetermined number of added components in a compounding machine such as a ribbon blender, a Henschel mixer, a high-speed mixer, or a single-screw or twin-screw extruder of this vinyl chloride resin composition, a Banbury mixer, a pressure kneader,
A method of uniformly kneading, dispersing and dissolving using a kneader such as a kneader or a roll may be used. In addition, no difference was observed in the effect of preventing the preservative from decreasing even if a step of dissolving the preservative in the plasticizer before and after the dispersing and dissolving was performed by the compounding machine. Dispersed and dissolved preservative containing vinyl chloride resin composition in this way, powder, block body, as a sheet or pellets, is sent to a molding step of the next enema dexterity container.

【0017】本発明で用いられる塩化ビニル系樹脂製容
器は、医療用プラスチックや食品容器に匹敵する安全性
が求められ、米国のFDA規格や塩ビ食品衛生協議会が
作成した「塩化ビニル樹脂製食品容器包装等に関する自
主規制基準(PL規格改定第9版)塩ビ食品衛生協議会
1989.3」(以下PL規格と略す)や日本医療用プラスチ
ック協会が作成した「医療用プラスチック自主規格」
(以下医療用規格と略す)に準拠する必要がある。した
がって、塩化ビニル系樹脂製容器を構成する可塑剤や基
幹ポリマーである塩化ビニル系樹脂、ポリマー添加剤、
安定剤、酸化防止剤、紫外線吸収剤、界面活性剤、滑
剤、着色剤、充填剤、発泡剤、その他の添加剤は、FD
A規格またはPL規格認可のものを用いるか、あるいは
認可外の薬剤を使用する場合は、これを含有する塩化ビ
ニル系樹脂製容器がPL規格の第2章に定められる材質
試験及び溶出試験(PL試験と略す)または医療用規格
に定められる医療用塩化ビニル樹脂コンパウンドI、II
(医療用試験と略す)に適合するようにしなければなら
ない。認可外の薬剤としては、例えば可塑剤であればト
リメリット酸エステル、ピロメリット酸のアルキルエス
テル、ジメチルカーボネートと多価アルコールのエステ
ルなど、安定剤であれば Ba-Zn系などがあり、他の組成
物も含めて、公知のものが挙げられる。
The vinyl chloride resin container used in the present invention is required to be as safe as medical plastics and food containers, and has been prepared by the US FDA standard and the PVC Food Sanitation Council. Voluntary Regulations on Containers and Packaging (PL Standard Revision 9th Edition) PVC Food Sanitation Council
1989.3 "(hereinafter abbreviated as PL standard) and" Medical Plastics Voluntary Standard "created by the Japan Medical Plastics Association.
(Hereinafter abbreviated as medical standard). Therefore, plasticizers and vinyl chloride resin as a base polymer that constitute the vinyl chloride resin container , polymer additives,
Stabilizers, antioxidants, ultraviolet absorbers, surfactants, lubricants, coloring agents, fillers, foaming agents, and other additives are FD
When using a product approved by the A standard or the PL standard, or using an unapproved chemical , make sure that the vinyl chloride resin container containing the material has a material test and a dissolution test (PL test) specified in Chapter 2 of the PL standard. Abbreviated as test) or medical vinyl chloride resin compounds I and II specified in medical standards
(Abbreviated as medical test). Examples of unapproved drugs include, for example, trimellitic acid esters, alkyl esters of pyromellitic acid, esters of dimethyl carbonate and polyhydric alcohols for plasticizers, and Ba-Zn based stabilizers for stabilizers. Known ones, including the composition, are mentioned.

【0018】 塩化ビニル系樹脂組成物から浣腸器用
器の成形は、ダイレクトブロー、シートブロー、インジ
ェクションブローなどブロー成形で行われるが、この加
工性や、浣腸操作性や手触感、防腐剤減少現象のいずれ
かに大きく影響を与える可塑剤と塩化ビニル系樹脂
組み合わせについて説明する。浣腸液中の防腐剤の減少
は、容器に防腐剤が移行するためで、特に容器を構成す
る可塑剤に防腐剤が吸収されるためと考えられる。しか
し可塑剤は容器の変形押圧力の手触感の調整ならびに加
工性向上のために必須である。これらの可塑剤は単独で
用いてもよいし、2種以上を組み合せてもよい。2種以
上を併用する場合、分配比は、各所定量の混合可塑剤液
層/あるいは各所定量の数種の可塑剤を練りこんだ塩化
ビニル系樹脂組成物と、グリセリン水溶液層間で測定す
る。可塑剤の添加量は塩化ビニル系樹脂 100重量部に対
して10〜 150重量部である。この量が10重量部未満では
可塑化効果が十分に発揮されず、流動性が低下して加工
性が悪くなったり、その成形品も硬くなって浣腸操作性
や手触感が悪くなる。 150重量部を超えるとドロウダウ
ンして加工性が悪くなり、また容器表面にタック性が現
れたり、機械的特性が低下する傾向が見られる。
The molding of the enema dexterity containers <br/> device from the vinyl chloride resin composition, direct blow, sheet blow is carried out by blow molding such as injection blow, the workability and, enemas operability and hand touch A combination of a plasticizer and a vinyl chloride-based resin which greatly affects any of the preservative reduction phenomena will be described. It is considered that the decrease of the preservative in the enema is due to the transfer of the preservative to the container, and particularly the preservative is absorbed by the plasticizer constituting the container. However, the plasticizer is indispensable for adjusting the touch feeling of the deformation pressing force of the container and improving the processability. These plasticizers may be used alone or in combination of two or more. When two or more kinds are used in combination, the distribution ratio is measured between a predetermined amount of the mixed plasticizer liquid layer / or a vinyl chloride resin composition kneaded with a predetermined amount of several kinds of plasticizer and the glycerin aqueous solution layer. The amount of the plasticizer is 10 to 150 parts by weight based on 100 parts by weight of the vinyl chloride resin. If the amount is less than 10 parts by weight, the plasticizing effect is not sufficiently exerted, the flowability is reduced, and the processability is deteriorated, and the molded product is hardened, and the enema operability and the feeling of touch are deteriorated. When the amount exceeds 150 parts by weight, drawdown is caused to deteriorate workability, and tackiness appears on the surface of the container, and mechanical properties tend to decrease.

【0019】本発明において基幹ポリマーとして用いら
れる塩化ビニル系樹脂は、例えば塩化ビニル単独重合
体、後塩素化塩化ビニル重合体、部分架橋塩化ビニル重
合体、塩化ビニルと塩化ビニル以外の重合性単量体の共
重合体、塩化ビニルをグラフトさせたグラフト共重合体
などの中から選択される。これら塩化ビニル系樹脂は、
単独で用いてもよいし、2種以上を組み合せてもよく、
その平均重合度は 300〜10,000の範囲にあることが望ま
しい。 300未満では十分な強度や変形応答性が得られな
いし、流動性が高すぎて加工性が悪くなったり、ドロウ
ダウンして均一な厚さの容器が得られない。10,000を超
えると加工時に弾性が発現し加工しにくくなる。
In the present invention , a polymer used as a backbone polymer
The vinyl chloride resin is, for example, a vinyl chloride homopolymer, a post-chlorinated vinyl chloride polymer, a partially cross-linked vinyl chloride polymer, a copolymer of vinyl chloride and a polymerizable monomer other than vinyl chloride, and a graft of vinyl chloride. Selected from grafted copolymers and the like. These vinyl chloride resins are
They may be used alone or in combination of two or more,
The average degree of polymerization is desirably in the range of 300 to 10,000. If it is less than 300, sufficient strength and deformation responsiveness cannot be obtained, and the flowability is too high, resulting in poor processability, or drawdown to fail to obtain a container having a uniform thickness. If it exceeds 10,000, elasticity is exhibited at the time of processing and processing becomes difficult.

【0020】 本発明に用いられる可塑剤フタル酸
ジエチル、フタル酸ジ−n−ブチル、フタル酸ジヘキシ
ル、フタル酸ジヘプチル、フタル酸ジオクチル(以下D
OPと略す)、フタル酸ジデシル、フタル酸ジイソノニ
ルなどのフタル酸エステル系;アジピン酸ジオクチル、
アジピン酸ジデシル、アジピン酸ジイソブチル、アジピ
ン酸ジイソノニル、アジピン酸n−オクチル、セバシン
酸ジ−n−ブチル、セバシン酸ジオクチル、アゼライン
酸エステルなどの脂肪族塩基酸エステル;リン酸エス
テル、クエン酸トリブチル、クエン酸モノ、ジ、トリス
テアリル、アセチルクエン酸トリエチル等のヒドロキシ
多価カルボン酸エステル;グリセリンなどの多価アルコ
−ルエステル;エポキシ化大豆油、エポキシ化ヒマシ油
などのエポキシ系可塑剤;ポリエステル系可塑剤などが
挙げられる。
[0020] Plasticizers used in the present invention, diethyl phthalate, di -n- butyl, dihexyl phthalate, diheptyl phthalate, dioctyl phthalate (hereinafter D
OP) , phthalic acid esters such as didecyl phthalate and diisononyl phthalate; dioctyl adipate;
Adipic acid didecyl, diisobutyl adipate, diisononyl adipate, n- octyl, sebacate -n- butyl, dioctyl sebacate, aliphatic dibasic acid esters such as azelaic acid ester; phosphoric acid esters, tributyl citrate, Polyhydric carboxylic acid esters such as mono-, di-, tristearyl citrate and triethyl acetyl citrate; polyhydric alcohol esters such as glycerin; epoxy-based plasticizers such as epoxidized soybean oil and epoxidized castor oil; polyester-based plasticizer Agents and the like.

【0021】このように浣腸操作性や手触感を重視する
のであれば可塑化効果が高い可塑剤を 150重量部を限
度に多く添加したり、重合度の高い塩化ビニル系樹脂を
選べばよいし、加工性を重視するのであれば重合度 3
00を限界に低重合度塩化ビニル系樹脂を選択し、可塑剤
は適量に調整するのがよい。またドロウダウン防止のた
めにアクリル系ポリマーの加工助剤を添加する従来の方
法を用いてもよい。本発明で用いられる塩化ビニル系樹
脂製容器は、前記防腐剤を前記手法で添加量を定め、前
記の塩化ビニル系樹脂と前記の方法で混合溶解し、前記
のブロー成形で浣腸器用容器に加工される。この塩化ビ
ニル系樹脂製容器に、用途に応じた浣腸液を、チューブ
ポンプやプランジャーポンプなどの定量吐出ポンプで注
入し、浣腸吐出口を熱溶着や超音波溶着、高周波溶着、
キャップ嵌め合い締めなどで封止して、本発明の塩化ビ
ニル系樹脂製容器を用いた浣腸が完成する。
If emphasis is placed on the enema operability and hand feeling as described above , a plasticizer having a high plasticizing effect may be added as much as 150 parts by weight or a vinyl chloride resin having a high degree of polymerization may be selected. If the emphasis is on processability , a degree of polymerization of 3
It is preferable to select a vinyl chloride resin having a low degree of polymerization with a limit of 00 and adjust the plasticizer to an appropriate amount. Further, a conventional method of adding an acrylic polymer processing aid for preventing drawdown may be used. Vinyl resin container chloride used in the present invention is to establish the amount of the preservative in the method, said mixed and dissolved in a vinyl chloride resin wherein the method, processing the enema dexterity container blow molding of the Is done. An enema liquid according to the application is injected into the vinyl chloride resin container by a fixed-rate discharge pump such as a tube pump or a plunger pump, and the enema discharge port is subjected to heat welding, ultrasonic welding, high-frequency welding,
Sealed with such fastening fitting cap, enema is completed using a vinyl resin container chloride of the present invention.

【0022】[0022]

【発明の効果】本発明によれば、塩化ビニル系樹脂製容
の持つ操作性や優れた手触感、成形性を保持しなが
ら、浣腸液中の防腐剤濃度の減少を防止し安全性及び
衛生面に優れた浣腸を安価に提供できる。
According to the present invention , it is possible to maintain the operability, excellent feel and feel, and moldability of a vinyl chloride resin container.
Et al., To prevent a decrease in preservative concentration enema solution can be provided at low cost an excellent enema safety and hygiene.

【0023】[0023]

【実施例】次に実施例により本発明をさらに詳細に説明
するが、本発明はこれらの実施例に限定されるものでは
ない。 (実施例1、比較例1〜3) 実施例1としてグリセリン50w/w%、イオン交換水50w/
w%のグリセリン水溶液及び防腐剤として0.0282w/v%の
−ヒドロキシ安息香酸エチル(以下EpHBと略す)0.01
12w/v%のp−ヒドロキシ安息香酸ブチル(以下BpHBと略
す)を溶解してなる浣腸液(以下浣腸液と略す)を注入
した塩化ビニル系樹脂製容器を例として、本発明を具体
的に説明する。それにはまず、グリセリン水溶液と可塑
剤との間で防腐剤の分配比を定量する、後述する方法で
分配比を決め、式1を使って算出したEpHB量及びBpHB量
塩化ビニル系樹脂に添加し、可塑剤と共に練りこん
塩化ビニル系樹脂製容器(以下組成の適量容器と略
す)を成形し、これについて、1年間、浣腸液中のEpHB
濃度及びBpHB濃度を追跡する保存試験行った。同様
に、比較例1としてEpHB、BpHB無添加の塩化ビニル系樹
脂製容器(以下組成の無添加容器と略す)、比較例2
として組成の適量容器よりもEpHB、BpHBの添加量が少
ない塩化ビニル系樹脂製容器(以下組成の不足量容器
と略す)、比較例3として適量容器よりもEpHB、BpHBの
添加量が多い塩化ビニル系樹脂製容器(以下では組成
の過剰量容器と略す)について保存試験を行った。
試験は特に温度調節していない室内に箱詰めして行っ
た。
EXAMPLES Next a more detailed description of the present invention through examples, but the present invention is not limited to these examples. (Example 1, Comparative Examples 1 to 3) Glycerin 50 w / w% as in Example 1, deionized water 50 w /
w% glycerin aqueous solution and 0.0282 w / v% p as preservative
-Ethyl hydroxybenzoate (hereinafter abbreviated as EpHB) and 0.01
The present invention will be specifically described by taking, as an example, a container made of a vinyl chloride resin into which an enema solution (hereinafter abbreviated as an enema solution) obtained by dissolving 12 w / v% butyl p-hydroxybenzoate (hereinafter abbreviated as BpHB) is used. explain. First, the distribution ratio of the preservative between the aqueous glycerin solution and the plasticizer is determined. The distribution ratio is determined by the method described later, and the amounts of EpHB and BpHB calculated by using Equation 1 are added to the vinyl chloride resin. and, molding the <br/> vinyl chloride resin container (hereinafter referred to as an appropriate amount container composition) is kneaded with a plasticizer, with this, 1 year, EphB enema solution
A storage test was performed to track concentrations and BpHB concentrations. As well
To, EphB as Comparative Example 1, (abbreviated as additive-free containers composition below) vinyl resin container chloride BpHB no addition, Comparative Example 2
As a container made of a vinyl chloride resin (hereinafter abbreviated as a container with an insufficient composition) in which the amount of EpHB and BpHB added is smaller than that of a container having an appropriate amount of composition. A storage test was performed on a container made of a resin (hereinafter abbreviated as a container with an excessive amount of composition). Each storage test was carried out in a box that was not particularly temperature-controlled.

【0024】 上記の方法で算出された 各容器の原料組成
と各成分の明細を表1に示す(表中の数字は重量部)
各容器の原料組成中、EpHB、BpHB以外の各成分の量割合
は全て共通にした。これらの成分はすべてFDA規格ま
たはPL規格で認可されたものである。
The raw material composition of each container which is calculated by the above method
And the details of each component are shown in Table 1 (the numbers in the table are parts by weight) .
In the raw material composition of each container, the proportions of the components other than EpHB and BpHB were all common. All of these components are approved by the FDA or PL standards.

【表1】 [Table 1]

【0025】まず分配比を測定する。測定操作はすべて
23℃で行った。DOP 91.38w/w%エポキシ化大豆油8.
62w/w%からなるDOP溶液に、EpHBを 4.8w/v%とBpHB
を 13.76w/v%に調整して溶解させた(以下このDOP溶
D1と略す)EpHBを0.0278w/v%とBpHBを 0.011
w/v%を含むグリセリン50w/w%、純水50w/w%のグリセリン
水溶液(以下GH1液と略す)を調製した。 200mlの分
液ロートに、これらD1液約50mlとGH1液約40mlとを
おおまかな量注ぎ、密栓して自動振盪機で激しく60分間
撹拌した。これを7日間静置したところ、目視で明確に
2層に分離した。密度の高いグリセリン水溶液層(以下
GH2液層と略す)が下層に、DOP溶液(以下D2
液層と称す)上層になった。D2液層及びGH2液層
中のEpHB、BpHB濃度を下記の方法で測定したところ、初
期のD1液、GH1液とは異なった濃度に変化してい
た。EpHB、BpHB共に、DOP溶液層からグリセリン水溶
液層に移行していた。
First, the distribution ratio is measured. All measurement operations
Performed at 23 ° C. DOP 91.38 w / w% and epoxidized soybean oil 8.
The DOP solution consisting of 62w / w%, 4.8w the EphB / v% and BpHB
It was dissolved by adjusting the 13.76w / v% (hereinafter this DOP solution abbreviated as D1 solution). EpHB 0.0278w / v% and BpHB 0.011
A glycerin aqueous solution (hereinafter abbreviated as GH1 solution) containing 50% w / v% glycerin and 50% w / w pure water was prepared. Approximately 50 ml of the D1 solution and approximately 40 ml of the GH1 solution were poured into a 200 ml separatory funnel, sealed, and vigorously stirred for 60 minutes with an automatic shaker. When this was allowed to stand for 7 days, it was clearly separated into two layers visually. A high-density glycerin aqueous solution layer (hereinafter abbreviated as GH2 liquid layer) is provided as a lower layer, and a DOP solution layer (hereinafter referred to as D2
Liquid layer) became the upper layer. When the EpHB and BpHB concentrations in the D2 liquid layer and the GH2 liquid layer were measured by the following method, the concentrations were different from those of the initial D1 and GH1 liquids. In both EpHB and BpHB, the DOP solution layer was transferred to the glycerin aqueous solution layer.

【0026】(EpHB、BpHB濃度測定法) EpHB、BpHBの定量は、公知の方法で行なった。即ち 195
nm〜350nm の吸光度検出器付きで吸光度積分機能付き高
速液体クロマトグラフィーで計測した。約30w/w%のメタ
ノール水溶液からなる溶離液を 1.0ml/分の流量で流
し、約0.02w/v%のEpHBのメタノール溶液10mlを注入する
と、最大吸収波長 260nm、保持時間4.35〜5.10分が観測
された。同じ操作でBpHBは最大吸収波長 260nm、保持時
間7.75〜9.42分と観測され、EpHBの方が保持時間が短
く、同波長 260nmで観測しても保持時間でEpHB、BpHBを
区別特定できることがわかった。またグリセリン水溶液
には 260nmに吸収がなく、DOP溶液は保持時間の異な
るものでEpHB、BpHB特定に影響を与えるものではなか
った。保持時間軸にたいする 260nm吸光度を積分したも
のは、検体中のEpHBやBpHB濃度に比例する。これを利用
して0〜0.05w/v%について既知濃度4点を調製して、吸
光度積分値と濃度の検量線を作成した。つづいて各検体
について吸光度積分値測定を行い、この検量線からEpH
B、BpHB濃度を読み取った。吸光度積分値が高すぎて検
量線外の場合は、メタノール水溶液で希釈して検量線に
乗せた。
(Method of Measuring EpHB and BpHB Concentrations) Quantification of EpHB and BpHB was performed by a known method. That is, 195
The measurement was performed by high performance liquid chromatography equipped with an absorbance integration function with an absorbance detector of nm to 350 nm. An eluent composed of about 30% w / w% aqueous methanol was flowed at a flow rate of 1.0 ml / min, and about 0.02% w / v% of methanol solution of EpHB was injected.The maximum absorption wavelength was 260 nm, and the retention time was 4.35 to 5.10 minutes. Observed. With the same operation, BpHB was observed with a maximum absorption wavelength of 260 nm and a retention time of 7.75 to 9.42 minutes, indicating that EpHB has a shorter retention time, and that even at the same wavelength of 260 nm, EpHB and BpHB can be distinguished and identified by the retention time. . The aqueous glycerin solution did not absorb at 260 nm, and the DOP solution had different retention times and did not affect the identification of EpHB and BpHB. The integrated value of 260 nm absorbance on the retention time axis is proportional to the EpHB and BpHB concentrations in the sample. Utilizing this, four known concentrations were prepared for 0 to 0.05 w / v%, and a calibration curve of the integrated absorbance value and the concentration was prepared. Subsequently, the absorbance integral value was measured for each sample, and the EpH
B, BpHB concentrations were read. If the absorbance integral was too high and outside the calibration curve, it was diluted with an aqueous methanol solution and placed on the calibration curve.

【0027】D2液層、GH2液層のEpHB、BpHB濃度を
モル濃度mol/mlに換算し、さらにGH2液層のEpHB、Bp
HB濃度を1とした時の比率で分配比を表し、表2、表3
に記載した。EpHBは、グリセリン水溶液に0.1010w/v%、
DOP溶液に 4.808w/v%で、グリセリン水溶液を1とし
とき、DOP溶液に 47.60倍分配された。BpHBは、グ
リセリン水溶液に 0.03197w/v%、DOP溶液に 14.72w/
v%で、グリセリン水溶液を1としたとき、DOP溶液に
460.3倍分配された。EpHB、BpHBともにDOP溶液に著
しく多量に分配され、特にBpHBのDOP溶液への分配比
が高かった。
The EpHB and BpHB concentrations of the D2 liquid layer and the GH2 liquid layer were converted into molar concentration mol / ml, and the EpHB and BpB of the GH2 liquid layer were further converted.
Table 2 and Table 3 show the distribution ratio as a ratio when the HB concentration is set to 1.
It described in. EpHB is 0.1010w / v% in glycerin aqueous solution,
When the glycerin aqueous solution was set to 1 at 4.808 w / v% in the DOP solution, the distribution was 47.60-fold in the DOP solution. BpHB is 0.03197w / v% in glycerin aqueous solution and 14.72w / v in DOP solution.
In v%, when a 1 glycerin aqueous solution, the DOP solution
It was distributed 460.3 times. Both EpHB and BpHB were remarkably distributed in the DOP solution, and the distribution ratio of BpHB to the DOP solution was particularly high.

【表2】 [Table 2]

【表3】 [Table 3]

【0028】次に実施例及び各比較例の浣腸液が初期の
EpHB、BpHB濃度を維持するように式1を使って塩化ビニ
ル系樹脂に添加する防腐剤量F(重量部)を算出する。
まず、EpHBの添加量FE を算出する。EpHBの分子量 E
166.18、維持濃度 E 0.0282 w/v% 、bE =47.57
として、 EE 4.808w/v% のEpHB可塑剤溶液
途調製し、この密度を測定したところ、d E(g/ml) 0.
986 であった。可塑剤添加量E=58重量部であることか
ら、式1より E 0.7999となり 0.8重量部練りこむ
こととした。同様にBpHB練りこみ量 B を算出する。
B 194.23、維持濃度 B(w/v%) 0.0112、bB 46
0.3 BB 14.72w/v% のBpHB可塑剤溶液の
B(g/ml) 0.986 、可塑剤添加量E=58重量部、したが
って B 3.199 となり、 3.2重量部練りこむこととし
た。このようにして組成を決定した。
Next, the embodimentAnd eachThe enema of the comparative example
Use equation 1 to maintain the EpHB and BpHB concentrations.
The amount F (parts by weight) of the preservative to be added to the resin is calculated.
First, the addition amount of EpHB FE Is calculated. EpHB molecular weightM E 
=166.18, maintenance concentrationC E =0.0282 w / v%, bE = 47.57
AsC E bE =4.808w / v% EpHBofPlasticizer solutionToAnother
When the density was measured, D E(g / ml)=0.
986. Plasticizer addition amount E = 58 parts by weight
From Equation 1,F E =0.7999, 0.8 parts by weight
I decided that. Similarly BpHBofKneading amountF B Is calculated.
M B =194.23, maintenance concentrationC B(w / v%)=0.0112, bB =46
0.3, C B bB =14.72w / v% BpHBofPlasticizer solutiond
B(g / ml)=0.986, plasticizer addition amount E = 58 parts by weight,
WhatF B =3.199 and 3.2 parts by weight
Was. Thus, the composition was determined.

【0029】実施例1の組成及び比較例1〜3
成の原料を用いて公知の方法で作製した各容器に
浣腸液120gを注入し、口部を高周波溶着で封止して、保
存試験を行った。浣腸液を封入した日を開始0日とし
た。1年間の保存試験結果を表4、表5に示した。開始
0日の各浣腸液の防腐剤量を 100としてEpHB、BpHBの濃
度変化をそれぞれ図1、図2に示した。
[0029] Using each set <br/> forming raw material composition and Comparative Examples 1 to 3 of Example 1 was injected enemas 120g in each container produced by a known method, sealing the mouth portion at a high frequency welding Stopped and a storage test was performed. The day when the enema was enclosed was defined as the starting day 0. Tables 4 and 5 show the results of the one-year storage test. Changes in the concentrations of EpHB and BpHB are shown in FIGS. 1 and 2, respectively, with the preservative amount of each enema solution on day 0 of the start as 100.

【表4】 [Table 4]

【表5】 [Table 5]

【0030】実施例1の組成の適量容器を用いた浣腸
のみ 100%に近いEpHB、BpHB濃度維持特性を示した。
比較例1の組成の無添加容器は防腐剤量が大きく減少
し 185日目に黴が観察された。比較例3の組成の過剰
量容器を用いた浣腸は20日目に粘膜刺激許容濃度を越
えてしまった。組成のEpHB、BpHB添加量は23℃におけ
るDOP溶液飽和量である。このように飽和量練りこめ
いというものではないことが確認できた。比較例2
の組成の不足量容器を用いた浣腸は 363日にわず
かな黴が観察された。以上実施例、比較例に示したよ
うに、適正量の防腐剤を塩化ビニル系樹脂に添加し、練
りこむことによって、黴の発生を防止できる、衛生面に
優れた浣腸器を提供することができる。
[0030] Using the appropriate amount containers of the composition of Example 1 enema
Only the vessel showed 100% EpHB and BpHB concentration maintenance characteristics.
In the non-added container having the composition of Comparative Example 1, the amount of the preservative was greatly reduced, and mold was observed on the 185th day. Enema with excess containers composition of Comparative Example 3 had exceeded the mucosal irritation permissible concentration on day 20. The amounts of EpHB and BpHB added in the composition are the saturated amounts of the DOP solution at 23 ° C. In this way it is not intended that not good if Kome Neri saturation amount could be confirmed. Comparative Example 2
Enema with shortage containers composition was slight mold was observed at day 363 days. Above embodiments, as shown in Comparative Examples, the addition of proper amounts of antiseptic agent in the vinyl chloride resin, by kneading, to provide a can prevent the occurrence of fungi, it is excellent in hygiene enema Can be.

【0031】(参考例1〜7)参考例1は実施例1の容器を使用した場合である(表4
及び表5参照)。 比較例2、比較例3浣腸器は、数式
1よりC= 100Fd/(E+F)bが導かれ、EpHB、BpHB
の添加部数E、可塑剤部数F、この部数で防腐剤と可塑
剤の溶液を調合しその密度をd、分配比測定試験から求
められたbE =47.57 、bB =460.3 を代入すれば、逆
に維持すべき浣腸液中の防腐剤濃度C(w/v%)を求めるこ
とができ。この防腐剤濃度C(w/v%)浣腸液を調製
し、比較例2、比較例3の器に充填し1年間放置
し、防腐剤濃度C(w/v%)と1年後の浣腸液中のEpHB、Bp
HBの濃度を比較検すれば、式1の確かさを確認できる
(これを参考例2、3とした)。また他の防腐剤のう
ち、p−ヒドロキシ安息香酸イソプロピル、p−ヒドロ
キシ安息香酸イソブチル、p−ヒドロキシ安息香酸プロ
ピルについても、実施例1と同様の方法で分配比を測定
し、維持すべき防腐剤濃度C(w/v%)を定め、この濃度の
浣腸液を調製し、容器に充填して浣腸として1年間
の放置試験を行った。この検せて行った(これを
参考例4〜7とした)。結果を表6に示す。
Reference Examples 1 to 7 Reference Example 1 is a case where the container of Example 1 was used (Table 4).
And Table 5). In the enemas of Comparative Examples 2 and 3 , C = 100Fd / (E + F) b is derived from Equation 1, and EpHB, BpHB
The number of added parts E, the number of plasticizer parts F, the preservative and the plasticizer solution are prepared in this number, the density is d, and b E = 47.57 and b B = 460.3 obtained from the distribution ratio measurement test are substituted. Ru can be obtained a preservative enema solution should be maintained in the reverse concentration C (w / v%). The enemas of the preservative concentration C (w / v%) was prepared, Comparative Example 2, was filled in a container of Comparative Example 3 was allowed to stand for one year, one year preservative concentration C (w / v%) EpHB, Bp in enema after
In comparison consider the concentration of HB, can be confirmed certainty of formula 1
(This was referred to as Reference Examples 2 and 3) . Among other preservatives, the distribution ratio of isopropyl p-hydroxybenzoate, isobutyl p-hydroxybenzoate and propyl p-hydroxybenzoate was measured in the same manner as in Example 1, and the preservative to be maintained was used. defining a concentration C (w / v%), a <br/> enemas of this concentration were prepared and shelf test of 1 year as enema and filled into containers. This consider went also to (this
Reference Examples 4 to 7) . Table 6 shows the results.

【表6】 [Table 6]

【0032】検体数10で、目標の維持すべき防腐剤濃度
C(w/v%)に対して1年後の浣腸液中の防腐剤濃度Hは平
均(95.3±2.40)%の的中率を示した。このように前記
分配試験より測定した分配比は各種防腐剤について広い
濃度範囲で適用でき、式1によって算出される防腐剤添
加量Fによって確実に製造後の浣腸液中の防腐剤濃度を
制御できるようになった。これによって黴の発生を防止
でき、衛生面に優れた浣腸器を提供できるようになっ
た。
For 10 samples, the preservative concentration H in the enema solution after one year was an average (95.3 ± 2.40)% of the target preservative concentration C (w / v%) to be maintained . showed that. As described above, the distribution ratio measured from the distribution test can be applied to various preservatives in a wide concentration range, and the preservative concentration in the enema solution after production can be reliably controlled by the preservative addition amount F calculated by the formula 1. It became so. As a result, the generation of mold can be prevented, and an enema having excellent hygiene can be provided.

【図面の簡単な説明】[Brief description of the drawings]

【図1】浣腸液中のEpHB濃度の1年間の変化を示すグラ
である
1 is a graph showing changes in one year EpHB concentration enema solution.

【図2】浣腸液中のBpHB濃度の1年間の変化を示すグラ
である
2 is a graph showing changes in one year BpHB concentration enema solution.

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】塩化ビニル系樹脂 100重量部可塑剤10〜
150重量部及びから求めた防腐剤F重量部から
なる塩化ビニル系樹脂製容器内に、防腐剤濃度0.015 〜
0.06w/v%の浣腸液が封入されてなることを特徴とする浣
腸器。 F=CbE/(100Cb) …………式1 [ここで、bは浣腸液と可塑剤及び防腐剤の共存時にお
ける防腐剤の浣腸液への分配比を1としたときの、防腐
剤の可塑剤への分配比、Cは浣腸液中で維持すること
必要な防腐剤濃度(w/v%)で、浣腸液 100ml中の防腐剤
重量gで表わす、Eは可塑剤添加重量部、dはCb/(1
00)(mol/ml) で表わされる防腐剤入りの可塑剤溶液の
密度(g/ml)Mは防腐剤の分子量をそれぞれ表わす。
1. 100 parts by weight of a vinyl chloride resin , a plasticizer 10 to
150 parts by weight, and preservatives F parts by weight calculated from the bottom following formula 1
Comprising vinyl chloride resin vessel, preservative concentration 0.015 ~
An enema characterized by encapsulation of 0.06 w / v% enema
Bowel. F = CbE / (100 d - Cb) ............ formula 1 [where, b is the time of the 1 the distribution ratio of the enema liquid preservative at coexistence of enemas and plasticizers and preservatives, distribution ratio to plasticizers preservatives, C is at <br/> necessary preservative concentration be maintained at enema solution (w / v%), a preservative in an enema solution 100ml
Expressed in parts by weight ( g) , E is a part by weight of a plasticizer, and d is Cb / (1
00 M) (mol / ml) density of the plasticizer solution preservatives containing represented by (g / ml), M represents respectively a molecular weight of preservative. ]
【請求項2】防腐剤がp−ヒドロキシ安息香酸エステル
である請求項1記載の浣腸器。
2. The method of claim 1, wherein the preservative is p-hydroxybenzoic acid ester.
The enema according to claim 1, which is:
JP6207282A 1994-08-31 1994-08-31 Enema Expired - Lifetime JP2793776B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6207282A JP2793776B2 (en) 1994-08-31 1994-08-31 Enema

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6207282A JP2793776B2 (en) 1994-08-31 1994-08-31 Enema

Publications (2)

Publication Number Publication Date
JPH0867791A JPH0867791A (en) 1996-03-12
JP2793776B2 true JP2793776B2 (en) 1998-09-03

Family

ID=16537223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6207282A Expired - Lifetime JP2793776B2 (en) 1994-08-31 1994-08-31 Enema

Country Status (1)

Country Link
JP (1) JP2793776B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021000390A (en) * 2019-06-24 2021-01-07 小林製薬株式会社 Fluid supply tool and method for producing fluid supply tool
JP7662302B2 (en) * 2019-06-24 2025-04-15 小林製薬株式会社 Vaginal douche and method for manufacturing same
JP2021000388A (en) * 2019-06-24 2021-01-07 小林製薬株式会社 Fluid supply tool and method for producing fluid supply tool
JP2021000389A (en) * 2019-06-24 2021-01-07 小林製薬株式会社 Fluid supply tool and method for producing fluid supply tool

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02151644A (en) * 1988-12-05 1990-06-11 Nippon Kayaku Co Ltd Fungusproof and mildewproof polyvinyl chloride molded item and preparation thereof
JPH04327858A (en) * 1991-04-26 1992-11-17 Sekisui Chem Co Ltd Container for enema

Also Published As

Publication number Publication date
JPH0867791A (en) 1996-03-12

Similar Documents

Publication Publication Date Title
US4528220A (en) Plastic bags for medical solutions and blood
JPH021506B2 (en)
EP0537863B1 (en) Use of a triglyceride compound as a hemolysis depressant
US3586514A (en) Thin-walled plastic container for beer
KR20040104466A (en) Multiple compartment bag assembly for dialysis fluid
JP2793776B2 (en) Enema
CN101962461B (en) Phthalate-free medical polyvinyl chloride plastic
CA1207489A (en) Resin composition suitable for use in medical devices
DE60005113T2 (en) Medical hose
US5270372A (en) Resin composition and food packaging materials formed therefrom
CA1154342A (en) Medical apparatus for parenteral liquids
JPS6237059B2 (en)
JP3310675B2 (en) Antithrombotic drug release device used to prevent blood coagulation in extracorporeal circulation of blood
JP3128400B2 (en) Vinylidene chloride copolymer composition
CN104403122B (en) A kind of blood stabilizer, blood bag and preparation method thereof
JP2006104242A (en) Polyvinyl chloride resin composition and stretch film using the same
JPH08509022A (en) Additives for polymer compositions
KR20010040862A (en) POLY ε-CAPROLACTONE PLASTICIZERS AND VINYLIC POLYMER COMPOSITIONS PLASTIFIED THEREWITH
US4883905A (en) Process for preparing citrates using organic titanates
JP2010155612A (en) Sealing member
PT91654B (en) VINYL CHLORIDE BASED RESIN PREPARATION PROCESS
JPS6169851A (en) Vinyl chloride resin composition for food packaging film
KR20030028844A (en) Aldehyde emission reduction for dibenzylidene sorbitol clarified plastics
JPS62246373A (en) Medical vinyl chloride resin composition
US5085863A (en) Tube provided with a white bismuth salt containing bismuth compound mixture as X-ray opaque agent

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100619

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130619

Year of fee payment: 15

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130619

Year of fee payment: 15

R370 Written measure of declining of transfer procedure

Free format text: JAPANESE INTERMEDIATE CODE: R370

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130619

Year of fee payment: 15

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term